Med-PaLM 2, every mention
13 scenes · ← back to Med-PaLM 2
tap a year for its mentions
every year anyone Elad Gil 9Karan Singhal 4Sarah Guo 2Dr. Shiv Rao 1
Verbatim, from the transcripts: the passages where Med-PaLM 2 comes up
No Priors Ep. 126 | With Cloudfare CEO Matthew Prince
No Priors Ep. 118 | With Anthropic Co-Founder Ben Mann
No Priors Ep. 110 | With Mercor CEO and Co-Founder Brendan Foody
No Priors Ep. 108 | With Abridge Founder and CEO Shiv Rao, MD
- ▶ 25:43 Dr. Shiv Rao And relatedly, if you go back and you look at, uh, some of the early research, you know, MedPalm II, for example, came out, I don't know what, two, three years ago now.
No Priors Ep. 74 | With Google DeepMind VP of Research Oriol Vinyals
No Priors Ep. 65 | With Scale AI CEO Alexandr Wang
No Priors Ep. 37 | With Kawal Gandhi
No Priors Ep. 35 | With Sarah Guo and Elad Gil
No Priors Ep. 17 | With Karan Singhal
- ▶ 0:07 Sarah Guo Today, we're speaking with Karin Singel, a researcher at Google, where he is a leader on medical AI, specifically on MedPalm II, where he and a team are working on a responsible path to generative AI in healthcare. 2 times in the scene
- ▶ 7:59 Elad Gil And so you did that, and then I guess if you start looking at this now shift from POM to POM-II and from MEDPOM to MEDPOM-II, did you basically just reproduce that same approach for MEDPOM-II or did you do anything different there?
- ▶ 26:08 Karan Singhal They, they're just kind of taking all the knowledge of POM and POM-II and then just kind of 2 times in the scene
- ▶ 30:09 Karan Singhal So you're already in a setting in which you need experts to be able to evaluate, uh, answers, and one thing we're seeing with MedPOM-II as we get closer to physician-level performance on medical question answering is that it's hard to tell…
- ▶ 36:28 Karan Singhal Like, think about just the improvement from MedPom-I, GPT-IV, MedPom-II in three months.